No hay motivo para alarmarse, pero puede resultar preocupante si no se est preparado
Meta-analyses of randomised controlled trials have demonstrated mean increases of approximately 24 beats per minute, with variation depending on the specific agent, dose, and patient population
To stay competitive, manufacturers must consider aligning todays investments with tomorrows potential breakthroughs
GLP-1RAs stimulate insulin secretion and suppress glucagon secretion, which may modify cardiac energy metabolism in T2DM patients [103]
Both GLP-1 RAs were administered in the morning and the approved titration schemes were applied
Those two numbers, 27 and 30, form the backbone of every eligibility conversation you will ever have about GLP-1 medications